Literature DB >> 26295986

Stable isotopes and LC-MS for monitoring metabolic disturbances in Friedreich's ataxia platelets.

Andrew J Worth1,2,3, Sankha S Basu1,3, Eric C Deutsch3,4, Wei-Ting Hwang2,5, Nathaniel W Snyder1,6, David R Lynch4, Ian A Blair1,2,3.   

Abstract

BACKGROUND: Friedreich's ataxia (FRDA) is an autosomal recessive disease with metabolic abnormalities that have been proposed to play an important role in the resulting neurodegeneration and cardiomyopathy. The inability to access the highly affected neuronal and cardiac tissues has hampered metabolic evaluation and biomarker development.
METHODS: Employment of a LC-MS-based method to determine whether platelets isolated from patients with FRDA exhibit differentiable metabolism compared with healthy controls.
RESULTS: Isotopologue analysis showed a marked decrease in glucose incorporation with a concomitant increase in palmitate-derived acyl-CoA thioesters in FRDA platelets compared with controls.
CONCLUSION: Our findings demonstrate that platelets can be used as a surrogate tissue for in vivo biomarker studies to monitor new therapeutic approaches for the treatment of FRDA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26295986      PMCID: PMC4620983          DOI: 10.4155/bio.15.118

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  60 in total

Review 1.  Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Authors:  Eugene Ciccimaro; Ian A Blair
Journal:  Bioanalysis       Date:  2010-02       Impact factor: 2.681

Review 2.  Metabolomics, pathway regulation, and pathway discovery.

Authors:  Guo-Fang Zhang; Sushabhan Sadhukhan; Gregory P Tochtrop; Henri Brunengraber
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

Review 3.  Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease.

Authors:  Sergey Zharikov; Sruti Shiva
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

4.  The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene.

Authors:  S M Forrest; M Knight; M B Delatycki; D Paris; R Williamson; J King; L Yeung; N Nassif; G A Nicholson
Journal:  Neurogenetics       Date:  1998-08       Impact factor: 2.660

5.  Reduced platelet glutamate uptake in Parkinson's disease.

Authors:  C Ferrarese; C Zoia; N Pecora; R Piolti; M Frigo; G Bianchi; G Sala; B Begni; R Riva; L Frattola
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

6.  Identification of lysine succinylation as a new post-translational modification.

Authors:  Zhihong Zhang; Minjia Tan; Zhongyu Xie; Lunzhi Dai; Yue Chen; Yingming Zhao
Journal:  Nat Chem Biol       Date:  2010-12-12       Impact factor: 15.040

7.  Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

Authors:  Joyce V Lee; Alessandro Carrer; Supriya Shah; Nathaniel W Snyder; Shuanzeng Wei; Sriram Venneti; Andrew J Worth; Zuo-Fei Yuan; Hee-Woong Lim; Shichong Liu; Ellen Jackson; Nicole M Aiello; Naomi B Haas; Timothy R Rebbeck; Alexander Judkins; Kyoung-Jae Won; Lewis A Chodosh; Benjamin A Garcia; Ben Z Stanger; Michael D Feldman; Ian A Blair; Kathryn E Wellen
Journal:  Cell Metab       Date:  2014-07-03       Impact factor: 27.287

Review 8.  Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.

Authors:  Katrina L Bogan; Charles Brenner
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

9.  Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia.

Authors:  Eunah Kim; Marek Napierala; Sharon Y R Dent
Journal:  Nucleic Acids Res       Date:  2011-07-10       Impact factor: 16.971

10.  Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.

Authors:  Matthias L Jauslin; Thomas Meier; Robin A J Smith; Michael P Murphy
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

View more
  13 in total

1.  Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia.

Authors:  Lili Guo; Qingqing Wang; Liwei Weng; Lauren A Hauser; Cassandra J Strawser; Agostinho G Rocha; Andrew Dancis; Clementina Mesaros; David R Lynch; Ian A Blair
Journal:  Anal Chem       Date:  2018-01-11       Impact factor: 6.986

2.  Metabolic tracing analysis reveals substrate-specific metabolic deficits in platelet storage lesion.

Authors:  Carrie Sims; Noelle Salliant; Andrew J Worth; Robert Parry; Clementina Mesaros; Ian A Blair; Nathaniel W Snyder
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

3.  LC-quadrupole/Orbitrap high-resolution mass spectrometry enables stable isotope-resolved simultaneous quantification and ¹³C-isotopic labeling of acyl-coenzyme A thioesters.

Authors:  Alexander J Frey; Daniel R Feldman; Sophie Trefely; Andrew J Worth; Sankha S Basu; Nathaniel W Snyder
Journal:  Anal Bioanal Chem       Date:  2016-03-11       Impact factor: 4.142

4.  LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism.

Authors:  Andrew J Worth; Dylan M Marchione; Robert C Parry; Qingqing Wang; Kevin P Gillespie; Noelle N Saillant; Carrie Sims; Clementina Mesaros; Nathaniel W Snyder; Ian A Blair
Journal:  J Vis Exp       Date:  2016-04-04       Impact factor: 1.355

5.  Company profile: BluePen Biomarkers LLC – integrated biomarker solutions.

Authors:  Ian A Blair; Clementina Mesaros; Patrick Lilley; Matthew Nunez
Journal:  Future Sci OA       Date:  2016-06-09

Review 6.  Drosophila melanogaster Models of Friedreich's Ataxia.

Authors:  P Calap-Quintana; J A Navarro; J González-Fernández; M J Martínez-Sebastián; M D Moltó; J V Llorens
Journal:  Biomed Res Int       Date:  2018-04-05       Impact factor: 3.411

Review 7.  Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease.

Authors:  Elisia Clark; Joseph Johnson; Yi Na Dong; Elizabeth Mercado-Ayon; Nathan Warren; Mattieu Zhai; Emily McMillan; Amy Salovin; Hong Lin; David R Lynch
Journal:  Neuronal Signal       Date:  2018-11-02

Review 8.  Impact of Drosophila Models in the Study and Treatment of Friedreich's Ataxia.

Authors:  Véronique Monnier; Jose Vicente Llorens; Juan Antonio Navarro
Journal:  Int J Mol Sci       Date:  2018-07-07       Impact factor: 5.923

9.  Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.

Authors:  David R Lynch; Jennifer Farmer; Lauren Hauser; Ian A Blair; Qing Qing Wang; Clementina Mesaros; Nathaniel Snyder; Sylvia Boesch; Melanie Chin; Martin B Delatycki; Paola Giunti; Angela Goldsberry; Chad Hoyle; Michael G McBride; Wolfgang Nachbauer; Megan O'Grady; Susan Perlman; S H Subramony; George R Wilmot; Theresa Zesiewicz; Colin Meyer
Journal:  Ann Clin Transl Neurol       Date:  2018-11-10       Impact factor: 4.511

Review 10.  Molecular Defects in Friedreich's Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities.

Authors:  Frances M Smith; Daniel J Kosman
Journal:  Front Mol Biosci       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.